149 related articles for article (PubMed ID: 25330222)
21. Current awareness in hematological oncology.
Hematol Oncol; 1995; 13(2):109-18. PubMed ID: 7797193
[No Abstract] [Full Text] [Related]
22. Allogeneic Hematopoietic Cell Transplantation Is Safe and Effective Treatment in Patients with Myelodysplastic Syndromes Seventy Years and Older.
Mukherjee S
Biol Blood Marrow Transplant; 2017 Jan; 23(1):1-2. PubMed ID: 27865911
[No Abstract] [Full Text] [Related]
23. Haploidentical allogeneic hematopoietic cell transplantation in adults using CD3/CD19 depletion and reduced intensity conditioning: a phase II study.
Federmann B; Bornhauser M; Meisner C; Kordelas L; Beelen DW; Stuhler G; Stelljes M; Schwerdtfeger R; Christopeit M; Behre G; Faul C; Vogel W; Schumm M; Handgretinger R; Kanz L; Bethge WA
Haematologica; 2012 Oct; 97(10):1523-31. PubMed ID: 22491731
[TBL] [Abstract][Full Text] [Related]
24. Complete and sustained remission of spondyloarthritis after allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome.
Simonetta F; Guerne PA; Tirefort Y; Masouridi-Levrat S; Roosnek E; Chalandon Y
Joint Bone Spine; 2015 May; 82(3):216-7. PubMed ID: 25547608
[No Abstract] [Full Text] [Related]
25. Allogeneic transplantation outcomes amongst a contemporary cohort of high-risk myelodysplastic syndrome and acute myeloid leukemia patients aged ≥70 years.
Lachowiez C; Cook RJ; Hayes-Lattin B; Maziarz RT; Borate U; Traer E; Leonard J; Newell L; Dao KH; Meyers G
Hematol Oncol Stem Cell Ther; 2019 Jun; 12(2):105-109. PubMed ID: 30836091
[TBL] [Abstract][Full Text] [Related]
26. [Allogeneic hematopoietic stem cell transplantation of myelodysplastic syndrome with pulmonary tuberculosis].
Yamashita K; Nomiyama J; Takahashi T; Ando T; Tsuru M; Matsubara A; Sato Y; Hatao K; Murakami K; Tanizawa Y
Nihon Naika Gakkai Zasshi; 2004 Oct; 93(10):2207-9. PubMed ID: 15552923
[No Abstract] [Full Text] [Related]
27. [Allogeneic hematopoietic stem cell transplantation for myeloma].
Nihon Rinsho; 2016 Jul; 74 Suppl 5():365-71. PubMed ID: 30620528
[No Abstract] [Full Text] [Related]
28. Therapy-related Myelodysplastic Syndrome after Autologous Stem Cell Transplantation Using Plerixafor for Mobilized Stem Cells in a Patient with Multiple Myeloma.
Tanaka H; Kuwabara C; Kayamori K; Shimizu R; Suzuki Y
J Clin Exp Hematop; 2018 Sep; 58(3):148-151. PubMed ID: 30089748
[No Abstract] [Full Text] [Related]
29. Successful treatment of myelodysplastic syndrome and Behcet colitis after allogeneic hematopoietic stem cell transplantation.
Kook MH; Yhim HY; Lee NR; Song EK; Kim HS; Yim CY; Kwak JY
Korean J Intern Med; 2014 Jan; 29(1):123-5. PubMed ID: 24574844
[No Abstract] [Full Text] [Related]
30. Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden.
Warlick ED; Cioc A; Defor T; Dolan M; Weisdorf D
Biol Blood Marrow Transplant; 2009 Jan; 15(1):30-8. PubMed ID: 19135940
[TBL] [Abstract][Full Text] [Related]
31. Hematopoietic Cell Transplantation Comorbidity Index Predicts Outcomes in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndromes Receiving CD34
Barba P; Ratan R; Cho C; Ceberio I; Hilden P; Devlin SM; Maloy MA; Barker JN; Castro-Malaspina H; Jakubowski AA; Koehne G; Papadopoulos EB; Ponce DM; Sauter C; Tamari R; van den Brink MRM; Young JW; O'Reilly RJ; Giralt SA; Perales MA
Biol Blood Marrow Transplant; 2017 Jan; 23(1):67-74. PubMed ID: 27789361
[TBL] [Abstract][Full Text] [Related]
32. Chronic graft-versus-host disease could ameliorate the impact of adverse somatic mutations in patients with myelodysplastic syndromes and hematopoietic stem cell transplantation.
Caballero JC; Sánchez Barba M; Hernández Sánchez JM; Such E; Janusz K; Sanz G; Cabrero M; Chillón C; Cervera J; Hurtado AM; Jerez A; Calderón Cabrera C; Valcárcel D; Lumbreras E; Abáigar M; López Cadenas F; Hernández Rivas JM; Del Cañizo MC; Díez Campelo M
Ann Hematol; 2019 Sep; 98(9):2151-2162. PubMed ID: 31312927
[TBL] [Abstract][Full Text] [Related]
33. [Transfusion protocols in hematopoietic stem cell allogeneic transplantation].
Bardiaux L; Assari S; Babinet J; Cavelier B; Raba M; Redersdorff JC; Roubinet F
Transfus Clin Biol; 2007 May; 14(1):94-9. PubMed ID: 17521940
[TBL] [Abstract][Full Text] [Related]
34. Higher rates of relapse in maternal recipients of haploidentical hematopoietic stem cell transplantation from adult offspring donors for AML and myelodysplastic syndrome.
Geethakumari PR; Leiby B; Nair R; Alpdogan SO; Carabasi M; Filicko-O'Hara J; Gaballa S; Kasner M; Klumpp T; Martinez-Outschoorn U; Palmisiano N; Wagner JL; Porcu P; Flomenberg N; Grosso D
Bone Marrow Transplant; 2017 Oct; 52(10):1465-1467. PubMed ID: 28759027
[No Abstract] [Full Text] [Related]
35. Outcomes of second allogeneic haematopoietic stem cell transplantation in patients with relapse of myelodysplastic syndrome.
Shimomura Y; Hara M; Tachibana T; Ohashi K; Sakura T; Fukuda T; Nakazawa H; Iwato K; Kanda Y; Ikeda T; Eto T; Kanda J; Ichinohe T; Atsuta Y; Ishikawa T; Ishiyama K
Br J Haematol; 2019 Jul; 186(1):86-90. PubMed ID: 30941758
[TBL] [Abstract][Full Text] [Related]
36. YKL-40 in allogeneic hematopoietic cell transplantation after AML and myelodysplastic syndrome.
Kornblit B; Wang T; Lee SJ; Spellman SR; Zhu X; Fleischhauer K; Müller C; Verneris MR; Müller K; Johansen JS; Vindelov L; Garred P
Bone Marrow Transplant; 2016 Dec; 51(12):1556-1560. PubMed ID: 27427920
[TBL] [Abstract][Full Text] [Related]
37. Which lower risk myelodysplastic syndromes should be treated with allogeneic hematopoietic stem cell transplantation?
Robin M; Fenaux P
Leukemia; 2020 Oct; 34(10):2552-2560. PubMed ID: 32661295
[TBL] [Abstract][Full Text] [Related]
38. Allogeneic Stem Cell Transplantation for Advanced Myelodysplastic Syndrome: Comparison of Outcomes between CD34
Tamari R; Oran B; Hilden P; Maloy M; Kongtim P; Papadopoulos EB; Rondon G; Jakubowski AA; Andersson BS; Devlin SM; Ahmed S; Popat UR; Ponce D; Chen J; Sauter C; Young JW; de Lima M; Perales MA; O'Reilly RJ; Giralt SA; Champlin RE; Castro-Malaspina H
Biol Blood Marrow Transplant; 2018 May; 24(5):1079-1087. PubMed ID: 29325829
[TBL] [Abstract][Full Text] [Related]
39. Therapy-related myeloid neoplasms after treatment for plasma-cell disorders.
Chung A; Liedtke M
Best Pract Res Clin Haematol; 2019 Mar; 32(1):54-64. PubMed ID: 30927976
[TBL] [Abstract][Full Text] [Related]
40. Siderotic plasma cells.
Singh ZN
Blood; 2011 Aug; 118(5):1196. PubMed ID: 21932457
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
